{"product_id":"biolegend-103132","title":"Biolegend, 103132, PerCP\/Cyanine5.5 anti-mouse CD45 Antibody, 100μg","description":"\u003cp\u003eCD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.\u003cbr\u003e\n100μg\u003cbr\u003e\nVerified Reactivity: Mouse\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Rat\u003cbr\u003e\nImmunogen: Mouse thymus or spleen\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with PerCP\/Cyanine5.5 under optimal conditions.\u003cbr\u003e\nConcentration: 0.2 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.* PerCP\/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)\u003cbr\u003e\nApplication Notes: Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45. Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin \u0026lt; 0.01 EU\/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC) Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP) Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC) Seaman WE. 1983. J. Immunol. 130:1713. (CMCD) Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC) Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed Liu F, et al. 2012. Blood. 119:3295. PubMed Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed\u003cbr\u003e\nProduct Citations: Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed Zaman R, et al. 2021. Immunity. :. PubMed Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed Bermea KC, et al. 2022. J Vis Exp. . PubMed Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed Axelrod ML, et al. 2022. Nature. 611:818. PubMed Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed Shi H, et al. 2022. Nutrients. 14:. PubMed Li J, et al. 2022. Elife. 11:. PubMed Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed He Y, et al. 2023. Biomolecules. 13:. PubMed Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed Pani F, et al. 2021. Endocrinology. 162:. PubMed Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed Liu W, et al. 2022. Biomedicines. 10: . PubMed Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed Wu X, et al. 2022. J Clin Med. 11: . PubMed Xie DH, et al. 2022. Med Phys. 49:6728. PubMed Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed Liang Y, et al. 2022. Theranostics. 12:7729. PubMed Xu H, et al. 2022. Aging Dis. 13:1875. PubMed Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed Liu G, et al. 2023. Commun Biol. 6:102. PubMed Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed Tang Y, et al. 2022. Dev Cell. 57:480. PubMed Li X, et al. 2022. Cell. 185:1709. PubMed Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed Tan L, et al. 2022. Aging Dis. 13:1562. PubMed Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed Krausgruber T, et al. 2020. Nature. 583:296. PubMed Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed Yang H, et al. 2019. Mol Metab. 23:24. PubMed Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed Li Z, et al. 2021. Immunology. 163:105. PubMed Browning D, et al. 2017. Gene Ther. 10.1038\/gt.2016.88. PubMed Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed Barry KC, et al. 2018. Nat Med. 24:1178. PubMed Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed Sasse C, et al. 2022. Pathogens. 11:. PubMed Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed Ren J, et al. 2021. Theranostics. 11:304. PubMed Craver BM, et al. 2020. Blood Adv. 4:312. PubMed Chen M, et al. 2021. Cancers (Basel). 13:. PubMed Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed Pan H, et al. 2020. Mol Psychiatry. . PubMed Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed Helm M, et al. 2022. Life (Basel). 12:. PubMed Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed Chung H, et al. 2021. Immune Netw. 21:e28. PubMed Shen H, et al. 2022. Nat Commun. 13:6030. PubMed Wang C, et al. 2021. Cell Stem Cell. . PubMed Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed Wei SC, et al. 2020. Cancer Discov. . PubMed Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed Voisin M, et al. 2021. Commun Biol. 4:420. PubMed Edwards CJ, et al. 2021. Br J Cancer. . PubMed Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed Deng Z, et al. 2017. Oncogene. 36:639. PubMed Linde N, et al. 2018. Nat Commun. 9:21. PubMed Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed Lee J, et al. 2022. Nat Commun. 13:1516. PubMed Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed Li N, et al. 2021. eLife. 10:00. PubMed Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed Shi R, et al. 2022. Theranostics. 12:875. PubMed Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed Formaglio P, et al. 2021. Immunity. 54:2724. PubMed Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed Wen Y, et al. 2020. Hypertension. 869:75. PubMed Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed Christ A, et al. 2018. Cell. 172:162. PubMed Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed Yang J, et al. 2022. Microbiome. 10:149. PubMed Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed Yang Z, et al. 2021. Sci Adv. 7:. PubMed Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed Sharma M, et al. 2020. Circ Res. 127:335. PubMed Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed Weinstock A, et al. 2021. Elife. :10. PubMed Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed Lang V, et al. 2021. Elife. 10:. PubMed Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed Chandra J, et al. 2016. Immunol Cell Biol. 10.1038\/icb.2016.83. PubMed Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed Gubin MM, et al. 2018. Cell. 175:1014. PubMed Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed Tuong ZK, et al. 2021. iScience. 24:103326. PubMed Thomas K, et al. 2022. JCI Insight. :. PubMed Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed Shan B, et al. 2020. Nat Metab. 1332:2. PubMed Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed Kalafati L, et al. 2020. Cell. 183:771. PubMed Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed Li M, et al. 2021. Cancers (Basel). 13:. PubMed Dong X, et al. 2022. Front Immunol. 13:896472. PubMed Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed Calle P, et al. 2021. Cells. 10:. PubMed Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed Wong NR, et al. 2021. Immunity. 54:2072. PubMed Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed Huo M, et al. 2017. FASEB J. 10.1096\/fj.201601030R. PubMed Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed Patel K, et al. 2016. Mucosal Immunol. 10.1038\/mi.2016.11. PubMed Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed Yin X, et al. 2020. Cell Rep. 33:108278. PubMed Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed Chen L, et al. 2021. Theranostics. 11:6668. PubMed Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed Zhang Z, et al. 2020. Nature. 579:415. PubMed Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed Liu SS, et al. 2021. Immunity. :. PubMed Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed Sharma M, et al. 2019. Immunometabolism. 1. PubMed Liang Z, et al. 2017. Autophagy. 14:505. PubMed Rosen SF, et al. 2022. Genome Med. 14:108. PubMed Schulze J, et al. 2021. Stroke. 52:2939. PubMed Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed Han Y, et al. 2019. J Clin Invest. 130:26. PubMed Riopel M, et al. 2019. Mol Metab. 20:89. PubMed Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed Liang Z, et al. 2022. iScience. 25:105233. PubMed Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed Song X, et al. 2022. Transl Oncol. 15:101306. PubMed Li X, et al. 2021. Front Immunol. 12:779560. PubMed Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed\u003cbr\u003e\nRRID: AB_893344 (BioLegend Cat. No. 103131) AB_893340 (BioLegend Cat. No. 103132)\u003cbr\u003e\nStructure: Protein tyrosine phosphatase (PTP) family, 180-240 kD\u003cbr\u003e\nDistribution: All hematopoietic cells except mature erythrocytes and platelets\u003cbr\u003e\nFunction: Phosphatase, T and B cell activation\u003cbr\u003e\nLigand\/Receptor: Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1\u003cbr\u003e\nCell Type: B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs\u003cbr\u003e\nBiology Area: Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells\u003cbr\u003e\nMolecular Family: CD Molecules\u003cbr\u003e\nAntigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85. 3. Kishihara K, et al. 1993. Cell 74:143. 4. Pulido R, et al. 1988. J. Immunol. 140:3851.\u003cbr\u003e\nGene ID: 19264\u003cbr\u003e\nUniProt: View information about CD45 on UniProt.org\u003cbr\u003e\nClone: 30-F11\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: T200, Ly-5, LCA\u003cbr\u003e\nIsotype: Rat IgG2b, κ\u003cbr\u003e\nQ: How stable is PerCP\/Cyanine5.5 tandem as compared to PerCP alone?\u003cbr\u003e\nA: PerCP\/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46862362837161,"sku":"103132","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/biolegend-103132","provider":"Iright","version":"1.0","type":"link"}